BHB also functions as a ligand for G protein-coupled receptors (GPCRs), specifically activating GPR109A and GPR41, which contribute to its anti-inflammatory, anti-tumor, and energy-expenditure regulatory effects [51,52,53,54,55]
In 2024, semaglutide 2.4 mg (Wegovy) received FDA approval for cardiovascular risk reduction in adults with established cardiovascular disease and either overweight or obesity, based on the SELECT trial
The goal is not to push through uncomfortable symptoms, but to understand what your body needs and communicate with your provider when something does not feel right
How Long Does It Take for Semaglutide to Start Working
Current clinical trials data suggest that retatrutide is a safe and effective medication with manageable side effects